Notice for rifampicin (Alphapharm Pty Ltd)
Active ingredients
rifampicin
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
For the treatment of patients with Buruli ulcer. Rifampicin is usually recommended to be used in combination with another antibiotic for the treatment of Buruli ulcer
Therapeutic area
Infectious diseases